International Journal of Vaccines and Technologies

Scope of the Journal

International Journal of Vaccines and Technologies, an open-access peer-reviewed journal dedicated to highlighting the importance of scientific advances in Vaccines research. The journal deals with important discoveries in vaccine research, such as the development and evaluation of vaccines, human and animal immune responses to vaccines, vaccine vectors, quantitative assays of vaccine efficacy, and clinical trials.

Emerging practices and the experiences in this field needs a critical and thorough discussion to spread the knowledge so that the researchers adopt them to pass on the benefits to the needy. In addition to publishing high-quality original research, the journal also publishes editorials, publishes commentaries, Case Studies, News, research highlights, and correspondence from readers, to provide state-of-the-art information for those interested in vaccine technologies. The International Editorial and Reviewers Team show impartial and transparent peer-review process, thus encouraging submissions from all over the world.

Authors are requested to submit manuscripts online or send as an e-mail attachment to the editorial office at

Related Keywords

Vaccine, Nonclinical Development of Vaccines, Vaccine Technology, Viral Immunology, Immunopathogenesis, Vaccine Vectors, Adjuvants and Immunomodulators, Prophylactic Vaccines, Therapeutic Vaccines, AIDS Vaccines, Gene Vaccines, Vaccines in Bioterrorism, Toxoid Vaccines, DNA Vaccines, Recombinant Vector Vaccines, Cancer Vaccines, Chicken pox Vaccines, Childhood Vaccines, Component Vaccines, Ebola Vaccines, HIV Vaccines Research & Development, Human Papilloma Virus Vaccine, Immunotherapeutics, MMR Vaccines, Polio Vaccines, Preclinical Vaccine Studies, Recombinant Vector Vaccines, Tdap Vaccines, Tuberculosis Vaccines, Vaccination, Vaccine Adjuvants, Vaccine Research & Development, Vaccines Dermatology, Vaccines Immunology, Veterinary Vaccines, Vaccines Epidemiology, Commercial Utilization, Policy, Safety, Vaccine Regulatory Issues